<< Passage of legislation could spell disaster for Idaho's health care system | Ampicillin activates torsinA, improves cell function to reduce movement disorders >>
Read in | English | हिन्दी | Русский

NASDAQ announces delisting of deCODE genetics common stock

Published on March 11, 2010 at 12:51 AM · No Comments

The NASDAQ Stock Market announced today that it will delist the common stock of deCODE genetics, Inc. deCODE genetics, Inc.'s stock was suspended on January 6, 2010 and has not traded on NASDAQ since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed. For news and additional information about the company, including the basis for the delisting and whether the company's securities are trading on another venue, please review the company's public filings or contact the company directly.

Source The NASDAQ Stock Market

Posted in:

Tags:

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading